31 October 2022
Ropes & Gray Advises Intrinsic Medicine in de-SPAC Business Combination Agreement with Phoenix Biotech Acquisition Corp.
Advising firms
Deal team
12 lawyers named| Lawyer | Firm | Seniority | Practice | Office |
|---|---|---|---|---|
| Daniel Forman Lead | Ropes & Gray | Partner | capital markets | Not stated |
| Carl Marcellino Lead | Ropes & Gray | Partner | private equity | Not stated |
| Bethany Hickey Lead | Ropes & Gray | Associate | private equity | Not stated |
| Sam Tansley Lead | Ropes & Gray | Associate | capital markets | Not stated |
| Renata Ferrari | Ropes & Gray | Partner | employment & benefits | Not stated |
| David McIntosh | Ropes & Gray | Partner | IP transactions | Not stated |
| Michael Lampert | Ropes & Gray | Partner | health care | Not stated |
| Elaine Murphy | Ropes & Gray | Partner | tax | Not stated |
| Danna Kivell | Ropes & Gray | Partner | employment & benefits | Not stated |
| Michael Mendelevich | Ropes & Gray | Counsel | tax | Not stated |
| Ryan Murphey | Ropes & Gray | Counsel | IP transactions | Not stated |
| Kevin Angle | Ropes & Gray | Counsel | data privacy & cybersecurity | Not stated |
9 more lawyers on this deal. Register free to see the full deal team, with seniority, practice and office.
REGISTER FREE SIGN INWant co-counsel patterns, repeat clients and alerts when these firms land their next deal? Get Pro.
Stated terms
- Stated value
- USD 136m ($136 million)
- What the figure measures
- Enterprise value
- Client
- Intrinsic Medicine, Inc.Target
- Counterparties
- Phoenix Biotech Acquisition Corp (Other)